Kennedy Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Buy
5,955
+489
+9% +$174K 0.04% 414
2025
Q4
$1.79M Buy
5,466
+128
+2% +$40.6K 0.04% 430
2025
Q3
$1.51M Buy
5,338
+2,503
+88% +$726K 0.03% 473
2025
Q2
$792K Buy
2,835
+119
+4% +$33.7K 0.02% 525
2025
Q1
$846K Sell
2,716
-1,215
-31% -$359K 0.02% 537
2024
Q4
$1.02M Sell
3,931
-20,648
-84% -$6.13M 0.02% 596
2024
Q3
$7.92M Buy
24,579
+1,565
+7% +$512K 0.17% 202
2024
Q2
$7.19M Buy
23,014
+11,617
+102% +$3.41M 0.15% 223
2024
Q1
$3.24M Buy
+11,397
New +$3.33M 0.07% 428

Other funds holding AMGN

Kennedy Capital Management's AMGN Position: Q1 2026 in Review

Kennedy Capital Management increased its Amgen (AMGN) stake by 8.9% in Q1 2026, buying an estimated $174K and bringing the position to 5,955 shares worth $2.1M. The position accounts for 0.04% of the portfolio, ranked #414.

Kennedy Capital Management first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.92M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kennedy Capital Management held 5,955 shares of Amgen worth $2.1M as of Q1 2026.
  • Kennedy Capital Management bought 489 Amgen shares in Q1 2026, an estimated $174K.
  • Amgen made up 0.04% of Kennedy Capital Management's portfolio in Q1 2026, its #414 holding.
  • Kennedy Capital Management first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • Kennedy Capital Management's Amgen position peaked at $7.92M in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.